Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06055439 |
| Title | A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Chimeric Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago | NOT_YET_RECRUITING | Chicago | Illinois | 60637 | United States | Details |
| University of Pennsylvania | RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |
| Sarah Cannon Research Institute | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| MD Anderson Cancer Center | NOT_YET_RECRUITING | Houston | Texas | 77030 | United States | Details |